EP2459617A4 - Aus monomeranaloga natürlicher metaboliten synthetisierte bioresorbierbare polymere - Google Patents

Aus monomeranaloga natürlicher metaboliten synthetisierte bioresorbierbare polymere

Info

Publication number
EP2459617A4
EP2459617A4 EP10805158.2A EP10805158A EP2459617A4 EP 2459617 A4 EP2459617 A4 EP 2459617A4 EP 10805158 A EP10805158 A EP 10805158A EP 2459617 A4 EP2459617 A4 EP 2459617A4
Authority
EP
European Patent Office
Prior art keywords
polymers synthesized
bioresorbable polymers
natural metabolites
monomeric analogues
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP10805158.2A
Other languages
English (en)
French (fr)
Other versions
EP2459617A1 (de
Inventor
Joachim B Kohn
Durgadas Bolikal
Ramiro Rojas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Original Assignee
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rutgers State University of New Jersey filed Critical Rutgers State University of New Jersey
Publication of EP2459617A1 publication Critical patent/EP2459617A1/de
Publication of EP2459617A4 publication Critical patent/EP2459617A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
    • C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
    • C08G79/025—Polyphosphazenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Materials For Medical Uses (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Prostheses (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Polyamides (AREA)
EP10805158.2A 2009-07-31 2010-07-31 Aus monomeranaloga natürlicher metaboliten synthetisierte bioresorbierbare polymere Withdrawn EP2459617A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23055809P 2009-07-31 2009-07-31
PCT/US2010/044049 WO2011014858A1 (en) 2009-07-31 2010-07-31 Bioresorbable polymers synthesized from monomer analogs of natural metabolites

Publications (2)

Publication Number Publication Date
EP2459617A1 EP2459617A1 (de) 2012-06-06
EP2459617A4 true EP2459617A4 (de) 2016-06-08

Family

ID=43529733

Family Applications (3)

Application Number Title Priority Date Filing Date
EP10805159.0A Withdrawn EP2459637A4 (de) 2009-07-31 2010-07-31 Biokompatible polymere für medizinische vorrichtungen
EP10805158.2A Withdrawn EP2459617A4 (de) 2009-07-31 2010-07-31 Aus monomeranaloga natürlicher metaboliten synthetisierte bioresorbierbare polymere
EP10805160.8A Active EP2459638B1 (de) 2009-07-31 2010-07-31 Monomere und daraus hergestellte phasengetrennte biokompatible polymerzusammensetzungen zur verwendung in der medizin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP10805159.0A Withdrawn EP2459637A4 (de) 2009-07-31 2010-07-31 Biokompatible polymere für medizinische vorrichtungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP10805160.8A Active EP2459638B1 (de) 2009-07-31 2010-07-31 Monomere und daraus hergestellte phasengetrennte biokompatible polymerzusammensetzungen zur verwendung in der medizin

Country Status (4)

Country Link
US (3) US8415449B2 (de)
EP (3) EP2459637A4 (de)
JP (2) JP5956337B2 (de)
WO (3) WO2011014860A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2373958C2 (ru) 2003-09-25 2009-11-27 Рутгерс, Дзе Стейт Юниверсити Полимерные по существу рентгеноконтрастные продукты для эмболотерапии
US8808357B2 (en) * 2010-04-06 2014-08-19 Poly-Med, Inc. Radiopaque iodinated and iodide-containing crystalline absorbable aliphatic polymeric materials and applications thereof
WO2012048276A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP2734248B1 (de) * 2011-07-20 2018-10-17 Tyrx, Inc. Wirkstofffreisetzendes netz zur verhinderung der infektion eindringender transdermaler vorrichtungen
WO2015073913A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (de) 2014-09-26 2021-03-24 Terumo BCT, Inc. Geplante fütterung
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CN106832235A (zh) * 2017-02-08 2017-06-13 新疆蓝山屯河化工股份有限公司 纺丝用聚丁二酸丁二醇酯及其制备方法
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
CN117247899A (zh) 2017-03-31 2023-12-19 泰尔茂比司特公司 细胞扩增
US12329876B2 (en) 2018-09-20 2025-06-17 Reva Medical, Llc Porous bioresorbable radiopaque embolic microspheres for drug delivery
US11866631B2 (en) * 2019-04-29 2024-01-09 Ecolab Usa Inc. Oxygenated aminophenol compounds and methods for preventing monomer polymerization
CN114502603B (zh) * 2019-10-11 2024-12-03 南洋理工大学 可降解聚合物材料
EP4314244B1 (de) 2021-03-23 2025-07-23 Terumo BCT, Inc. Zellerfassung und -erweiterung
US12209689B2 (en) 2022-02-28 2025-01-28 Terumo Kabushiki Kaisha Multiple-tube pinch valve assembly
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019996A1 (en) * 1995-11-27 1997-06-05 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
WO2007047244A2 (en) * 2005-10-12 2007-04-26 Bezwada Biomedical Llc Functionalized amino acids and absorbable polymers therefrom
WO2007056134A2 (en) * 2005-11-03 2007-05-18 Tyrx Pharma Inc. Resorbable phenolic polymers
WO2010033640A1 (en) * 2008-09-16 2010-03-25 Rutgers, The State University Of New Jersey Bioresorbable polymers synthesized from monomer analogs of natural metabolites

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1272094A (en) 1968-03-22 1972-04-26 Inter Polymer Res Corp Process of preparation of polyesters and derivatives
BE758156R (fr) 1970-05-13 1971-04-28 Ethicon Inc Element de suture absorbable et sa
US4694044A (en) * 1984-03-09 1987-09-15 Research Development Corp. Of Japan Adsorbent
US4822829A (en) 1985-05-07 1989-04-18 Huels Troisdorf Aktiengesellschaft Radiation-curable macromers based on (meth)acrylate-functional polyesters, and their use
US5003004A (en) 1986-04-18 1991-03-26 E. I. Du Pont De Nemours And Company Tough flexible polymer blends
US4744365A (en) 1986-07-17 1988-05-17 United States Surgical Corporation Two-phase compositions for absorbable surgical devices
US4916204A (en) * 1987-07-31 1990-04-10 Massachusetts Institute Of Technology Pure polyanhydride from dicarboxylic acid and coupling agent
US5066772A (en) 1987-12-17 1991-11-19 Allied-Signal Inc. Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
US4980449A (en) 1988-07-14 1990-12-25 Rutgers, The State University Polyiminocarbonate synthesis
US5660822A (en) 1990-05-14 1997-08-26 University Of Medicine & Dentistry Of N.J. Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
US5219564A (en) 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5216115A (en) 1990-06-12 1993-06-01 Rutgers, The State University Of New Jersey Polyarylate containing derivatives of the natural amino acid L-tyrosine
US5587507A (en) 1995-03-31 1996-12-24 Rutgers, The State University Synthesis of tyrosine derived diphenol monomers
US5099060A (en) 1990-06-12 1992-03-24 Rutgers, The State University Of New Jersey Synthesis of amino acid-derived bioerodible polymers
US5403347A (en) 1993-05-27 1995-04-04 United States Surgical Corporation Absorbable block copolymers and surgical articles fabricated therefrom
US5431679A (en) 1994-03-10 1995-07-11 United States Surgical Corporation Absorbable block copolymers and surgical articles fabricated therefrom
DE59508729D1 (de) 1994-08-10 2000-10-26 Peter Neuenschwander Biokompatibles Blockcopolymer
US5702717A (en) 1995-10-25 1997-12-30 Macromed, Inc. Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
IT1282585B1 (it) 1996-02-08 1998-03-31 Europ Copolimeri a blocchi poliesterepolicarbonato contenenti segmenti di poli(caprolattone)e loro uso per la preparazione di matrici
US6319492B1 (en) 1996-11-27 2001-11-20 Rutgers, The State University Copolymers of tyrosine-based polyarylates and poly(alkylene oxides)
US6120491A (en) * 1997-11-07 2000-09-19 The State University Rutgers Biodegradable, anionic polymers derived from the amino acid L-tyrosine
DE69821600T2 (de) 1997-02-18 2005-01-05 Rutgers, The State University Von hydroxysäuren abgeleitete monomere und daraus hergestellte polymere
US6355754B1 (en) 1997-05-09 2002-03-12 3M Innovative Properties Company High refractive index chemical composition and polymers and polymeric material derived therefrom
DE19723895C2 (de) 1997-06-06 1999-06-02 Yoon Jick Dipl Ing Lee Bioabbaubare Polyesterurethane, Verfahren zu ihrer Herstellung sowie ihre Verwendung
EP0896013A1 (de) 1997-08-06 1999-02-10 Shimadzu Corporation Vernetztes Polycarbonatharz und Polymilchsäurezusammensetzung, die dieses Polycarbonatharz enthält
US5854383A (en) 1997-10-06 1998-12-29 Ethicon, Inc. Aliphatic polyesters of trimethylene carbonate epsilon-caprolactone and glycolide
AU737151B2 (en) * 1997-11-07 2001-08-09 Rutgers, The State University Radio-opaque polymeric biomaterials government license rights
US6602497B1 (en) 1997-11-07 2003-08-05 Rutgers, The State University Strictly alternating poly(alkylene oxide ether) copolymers
US6316585B1 (en) 1999-01-18 2001-11-13 Council Of Scientific And Industrial Research Process for the preparation of enzymatically degradable polymers
US6338739B1 (en) 1999-12-22 2002-01-15 Ethicon, Inc. Biodegradable stent
US7169187B2 (en) 1999-12-22 2007-01-30 Ethicon, Inc. Biodegradable stent
AU784226B2 (en) * 1999-12-31 2006-02-23 Rutgers, The State University Pharmaceutical formulation for regulating the timed release of biologically active compounds based on a polymer matrix
BR0005525A (pt) 2000-11-23 2003-09-02 Fundacao Oswaldo Cruz Inibidores de protease e seus usos farmacêuticos
EP1238995A1 (de) 2001-03-06 2002-09-11 Vantico AG Hochfunktionelle Polymere
US6592899B2 (en) 2001-10-03 2003-07-15 Macromed Incorporated PLA/PLGA oligomers combined with block copolymers for enhancing solubility of a drug in water
US8591951B2 (en) 2002-05-15 2013-11-26 Joachim B. Kohn Tri-block copolymers for nanosphere-based drug delivery
US6943214B2 (en) 2003-05-13 2005-09-13 E. I. Du Pont De Nemours And Company Toughened polyoxymethylene-poly(lactic acid) compositions
ES2537307T3 (es) 2003-07-16 2015-06-05 Eidgenössische Technische Hochschule Zürich Copolímero de bloque biocompatible, degradable
US7479157B2 (en) 2003-08-07 2009-01-20 Boston Scientific Scimed, Inc. Stent designs which enable the visibility of the inside of the stent during MRI
RU2373958C2 (ru) 2003-09-25 2009-11-27 Рутгерс, Дзе Стейт Юниверсити Полимерные по существу рентгеноконтрастные продукты для эмболотерапии
US20070117959A1 (en) 2003-12-15 2007-05-24 The Children's Hospital Of Philadelphia Novel polyesters
US7939611B2 (en) 2004-07-08 2011-05-10 Reva Medical, Inc. Side-chain crystallizable polymers for medical applications
US20060034891A1 (en) * 2004-08-12 2006-02-16 Laurie Lawin Biodegradable controlled release bioactive agent delivery device
US20060034769A1 (en) 2004-08-13 2006-02-16 Rutgers, The State University Radiopaque polymeric stents
RU2396289C2 (ru) 2004-08-13 2010-08-10 Рева Медикал, Инк. Саморассасывающиеся рентгеноконтрастные по своей природе полимеры для многоцелевого использования
US7935843B2 (en) * 2005-12-09 2011-05-03 Bezwada Biomedical, Llc Functionalized diphenolics and absorbable polymers therefrom
US9603941B2 (en) 2006-01-24 2017-03-28 Minghui Chai Method of preparing dendritic drugs
US7964210B2 (en) 2006-03-31 2011-06-21 Abbott Cardiovascular Systems Inc. Degradable polymeric implantable medical devices with a continuous phase and discrete phase
US8378072B2 (en) 2006-04-13 2013-02-19 Declion Pharmaceuticals, Inc. Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
US8486135B2 (en) 2006-06-01 2013-07-16 Abbott Cardiovascular Systems Inc. Implantable medical devices fabricated from branched polymers
EP2032614A2 (de) 2006-06-06 2009-03-11 Rutgers, The State University Of New Jersey Jodhaltige polymere
US7923022B2 (en) 2006-09-13 2011-04-12 Advanced Cardiovascular Systems, Inc. Degradable polymeric implantable medical devices with continuous phase and discrete phase
AU2007340273B2 (en) 2006-10-17 2012-08-30 Rutgers, The State University Of New Jersey N-substituted monomers and polymers
US20080243228A1 (en) 2007-03-28 2008-10-02 Yunbing Wang Implantable medical devices fabricated from block copolymers
US20080269874A1 (en) 2007-04-30 2008-10-30 Yunbing Wang Implantable medical devices fabricated from polymers with radiopaque groups
US20080299177A1 (en) 2007-06-06 2008-12-04 Biovaluation & Analysis, Inc. Supramolecular Complexes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
US20090004243A1 (en) 2007-06-29 2009-01-01 Pacetti Stephen D Biodegradable triblock copolymers for implantable devices
US20090035350A1 (en) 2007-08-03 2009-02-05 John Stankus Polymers for implantable devices exhibiting shape-memory effects
US7956100B2 (en) 2007-09-28 2011-06-07 Abbott Cardiovascular Systems Inc. Implantable medical devices fabricated from block copolymers
CA2737763C (en) * 2008-10-11 2019-04-09 Rutgers, The State University Of New Jersey Phase-separated biocompatible polymer compositions for medical uses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997019996A1 (en) * 1995-11-27 1997-06-05 Rutgers, The State University Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
WO2007047244A2 (en) * 2005-10-12 2007-04-26 Bezwada Biomedical Llc Functionalized amino acids and absorbable polymers therefrom
WO2007056134A2 (en) * 2005-11-03 2007-05-18 Tyrx Pharma Inc. Resorbable phenolic polymers
WO2010033640A1 (en) * 2008-09-16 2010-03-25 Rutgers, The State University Of New Jersey Bioresorbable polymers synthesized from monomer analogs of natural metabolites

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2011014858A1 *

Also Published As

Publication number Publication date
EP2459617A1 (de) 2012-06-06
US20120178885A1 (en) 2012-07-12
JP2013501106A (ja) 2013-01-10
EP2459637A1 (de) 2012-06-06
US9080015B2 (en) 2015-07-14
EP2459638A4 (de) 2016-06-08
US20120189713A1 (en) 2012-07-26
WO2011014860A1 (en) 2011-02-03
US20120197001A1 (en) 2012-08-02
JP5944314B2 (ja) 2016-07-05
EP2459637A4 (de) 2016-06-08
JP2013501107A (ja) 2013-01-10
JP5956337B2 (ja) 2016-07-27
US8415449B2 (en) 2013-04-09
WO2011014859A1 (en) 2011-02-03
WO2011014858A1 (en) 2011-02-03
US8765161B2 (en) 2014-07-01
EP2459638B1 (de) 2017-09-27
EP2459638A1 (de) 2012-06-06

Similar Documents

Publication Publication Date Title
EP2459617A4 (de) Aus monomeranaloga natürlicher metaboliten synthetisierte bioresorbierbare polymere
EP2334712A4 (de) Aus monomeranaloga natürlicher metaboliten synthetisierte bioresorbierbare polymere
EP2250241A4 (de) Synthese von bioschmiermitteln auf diesterbasis aus epoxiden
EP2443163A4 (de) Polymerisation von isopren aus erneuerbaren ressourcen
EP2244993A4 (de) Herstellung von ethanol aus methanol
EP2563800A4 (de) Kristallisationsvermittler zur synthese von metallorganischen gerüsten
SMT201600316B (it) E PROCEDIMENTO PER LA PREPARAZIONE DELL'ESTERE 1-METILETILICO DI N-[(2'R)- 2'-DEOSSI-2'-FLUORO-2'-METIL-P-FENIL-5'- URIDILlL]-L-ALANINA
BRPI0923890A2 (pt) Síntese de estilpiridinas 18f- radiomarcadas a partir de percussores tosilatos de composições farmacêuticas estáveis do mesmo.
BRPI1013015A2 (pt) "osteosíntese com nanoprata"
EP2309973A4 (de) Kontinuierlich feuchtigkeitsspendende zusammensetzungen
EP2377028A4 (de) Änderung von befehlen
BRPI0905680A2 (pt) "composição farmacêutica de uma composição farmacêutica"
FR2934147B1 (fr) Implant d'osteosynthese vertebrale
FR2956972B1 (fr) Plaque d'osteosynthese articulee
ZA201107336B (en) Synthesis of 2'-o-fucosyllactose
BR112013006165A2 (pt) composição de revestimento à base d'água
BRPI0914450A2 (pt) "equipamento de estrumental círurgico"
BR112013003819A2 (pt) método para a síntese de moleculas contendo furano de fórmula i a partir de moléculas contendo furano de fórmula ii
EP2318314A4 (de) Synthese eines kristallinen silikoaluminiumphosphats
BR112012004664A2 (pt) "filme formado a partir de um copoliéster"
EP2417147A4 (de) Multplex-orte für polymersynthese
EP2462115A4 (de) Enzymatische transaminierung von cyclopamin-analogen
EP2407566A4 (de) Element aus magnesiumlegierung
EP2603516A4 (de) Synthese von 2'-desoxy-2'-[18f-]fluor-5-methyl-1-b-d-arabinofuranosyluracil (18f-fmau)
BRPI0823084A2 (pt) Método de síntese de uma mistura de oligômeros substancialmente monodispersa

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20160509

RIC1 Information provided on ipc code assigned before grant

Ipc: C08G 65/00 20060101AFI20160502BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20161207